Helicobacter

Papers
(The H4-Index of Helicobacter is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults45
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study37
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial37
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection31
Transmission routes and patterns of helicobacter pylori30
PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis30
An overview of traditional Chinese medicine therapy for Helicobacter pylori–related gastritis28
CRISPR‐based detection of Helicobacter pylori in stool samples28
Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation26
The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis25
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis25
Impact of smoking on the eradication of Helicobacter pylori24
Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short‐chain fatty acids in Helicobacter pylori‐infected mice23
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China23
Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta‑analysis23
Association between bacteria other than Helicobacter pylori and the risk of gastric cancer22
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double‐blind, placebo‐controlled, randomiz22
Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice21
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota21
Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis21
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention21
Efficacy of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue lymphoma: A meta‐analysis21
0.15337610244751